John Furey - 02 Jul 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
John Furey, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
02 Jul 2024
Net transactions value
$0
Form type
4
Filing time
03 Jul 2024, 18:12:47 UTC
Previous filing
01 Jul 2024
Next filing
16 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +16,760 $0.000000 16,760 02 Jul 2024 Common Stock 16,760 $76.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option shall vest over 36 months, 1/3 of which will vest on July 2, 2025 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.